Posts tagged brain

Article Date: 04 Feb 2012 - 10:00 PST

The February edition of Neurosurgery reports that animal experiments in brain-injured rats have shown that stem cells injected via the carotid artery travel directly to the brain, greatly enhancing functional recovery. The study demonstrates, according to leading researcher Dr Toshiya Osanai, of Hokkaido University Graduate School of Medicine in Sapporo, Japan, that the carotid artery injection technique could, together with some form of in-vivo optical imaging to track the stem cells after transplantation, potentially be part of a new approach for stem cell transplantation in human brain trauma injuries (TBI).

Dr. Osanai and team assessed a new “intra-arterial” technique of stem cell transplantation in rats, with the aim of delivering the stem cells directly to the brain without having to go through the general circulation. They induced TBI in the animals before injecting stem cells into the carotid artery seven days later.

The stem cells were obtained from the rats’ bone marrow and were labeled with “quantum dots” prior to being injected. Quantom dots are a biocompatible, fluorescent semiconductor created with nanotechnology that emit near-infrared light with much longer wavelengths that penetrate bone and skin, enabling a non-invasive method of monitoring the stem cells for a period of four weeks following transplantation.

This in vivo optical imaging technique enabled the scientists to observe that the injected stem cells entered the brain on the first attempt, without entering the general circulation. They observed that the stem cells started migrating from the capillaries into the injured part of the brain within three hours.

At week 4, the researchers noted that the rats in the stem cell transplant group achieved a substantial recovery of motor function, compared with the untreated animals that had no signs of recovery.

The team learnt, after examining the treated brains, that the stem cells had transformed into different brain cell types and aided in healing the injured brain area.

Over the last few years, the potential of stem cell therapy for curing and treating illnesses and conditions has been growing rapidly. Below is a list of some of its possible uses.

(Photo by: Mikael Häggström)

Developing stem cell therapy for brain injury in human patients

Stem cells represent a potential, new important method of treatment for those who suffered brain injuries, TBI and stroke. But even though bone marrow stem cells, similar to the ones used in the new study, are a promising source of donor cells, many questions remain open regarding the optimal timing, dose and route of stem cell delivery.

In the new animal study, the rats were injected with the stem cells one week after TBI. This is a “clinically relevant” time, given that this is the minimum time it takes to develop stem cells from bone marrow.

Transplanting the stem cells into the carotid artery is a fairly simple procedure that delivers the cells directly to the brain.

The experiments have also provided key evidence that stem cell treatment can promote healing after TBI with a substantial recovery of function.

Dr. Osanai and team write that by using in vivo optical imaging:

"The present study was the first to successfully track donor cells that were intra-arterially transplanted into the brain of living animals over four weeks."

A similar form of imaging technology could also prove beneficial for monitoring the effects of stem cell transplantation in humans, although the tracking will pose challenges, due to the human skull and scalp being much thicker than in rats.

The researchers conclude:

"Further studies are warranted to apply in vivo optical imaging clinically.”

Written by Petra Rattue

Source: Medical News Today

by Jon Cohen on 1 February 2012, 6:00 PM

Synaptic division. Compared with chimpanzees, human children children slowly wire their brains. Credit: Fotosearch

February 3, 2012

Schematic drawing of the upright STED microscope used for the experiments. Image: Science, DOI:10.1126/science.1215369

(PhysOrg.com) — Ever since scientists began studying the brain, they’ve wanted to get a better look at what was going on. Researchers have poked and prodded and looked at dead cells under electron microscopes, but never before have they been able to get high resolution microscopic views of actual living brain cells as they function inside of a living animal. Now, thanks to work by physicist Stefan Hell and his colleagues at the Max Planck Institute in Germany, that dream is realized. In a paper published in Science, Hell and his team describe the workings of their marvelous discovery.

Hell (which in German means “bright”) and others at the Institute have been working for years on ultra high resolution microscopes that go by the name “stimulated emission depletion” or STED microscopes. Now, they’ve taken their work to a whole new level by cutting away a small portion of a mouse’s skull and replacing it with a glass window and then placing their latest STED microscope against the glass to peer inside. To make it easier to see what is what, the team first genetically altered the mouse to make certain brain cells fluorescent. Then, to allow for focusing exclusively on just those cells that are lit up, they added software to the microscope to blot out anything that was not lit up. The result is super high resolution real time imagery of the neurons that exist on the exterior part of a living mouse brain. 

(video)

STED time-lapse recording of a single spine at an interval of 10 seconds. The measurement includes 128 z-stacks consisting of 5 slices each. Most of the rapid remodeling of the spine head appears continuous and smooth at this frame rate. No damage is observed at the dendrite or the spine after recording a total of 640 slices. The movie was acquired in a different experiment than the spines in Fig.1. Scale bar = 1µm. Video: DOI:10.1126/science.1215369

The new microscope provides clear resolution down to 70 nanometers, which is four times that ever achieved before and is enough to allow scientists to see the actual movement of dendritic spines, which may help researches understand why they do so.

It is likely that researchers will find many varied uses for the new microscope. One prominent area will almost certainly involve looking into what psychiatric drugs are really doing within synapses, perhaps leading to breakthroughs in pharmaceutical drugs that are better able to target specific illnesses.

One downside to any new scientific breakthrough however, is the natural tendency of many to move from excitation, to wondering about what will come next. In this case, Hell and his team have already started contemplating ideas on ways to allow researchers to study any cell in the living brain at such high resolution, not just those that lie on the surface.

More information: Nanoscopy in a Living Mouse Brain, Science 3 February 2012: Vol. 335 no. 6068 p. 551. DOI: 10.1126/science.1215369

"Renowned physicist invents microscope that can peer at living brain cells." February 3rd, 2012. http://www.physorg.com/news/2012-02-renowned-physicist-microscope-peer-brain.html

ScienceDaily (Feb. 3, 2012) — When a patient afflicted with schizophrenia hears inner voices something is taking place inside the brain that prevents the individual from perceiving real voices. A simple electronic application may help the patient learn to shift focus.

Image captures of the brain show how neurons are activated in healthy control subjects when hearing actual voices (top row) whereas activation fails to occur in patients who experience auditory hallucinations. (Credit: Kenneth Hugdahl)

"The patient experiences the inner voices as 100 per cent real, just as if someone was standing next to him and speaking" explains Professor Kenneth Hugdahl of the University of Bergen. "At the same time, he can’t hear voices of others actually present in the same room."

Auditory hallucinations are one of the most common symptoms associated with schizophrenia.

Neural activity ceases

Dr Hugdahl’s research group has made use of a variety of neuroimaging techniques, including functional magnetic resonance imaging technology (fMRI) to enable them quite literally to see what happens inside the brain when the inner voices make their presence known. The project received funding under the NevroNor national initiative on neuroscientific research administered under the auspices of the Research Council of Norway

Images of patients’ brains reveal a spontaneous activation of neurons in a particular area of the brain — specifically the rear, upper region of the left temporal lobe. This is the area responsible for speech perception, and when healthy people hear speech it becomes activated. So what happens when patients with schizophrenia hear a real voice and a hallucinatory one at the same time?

"It would be natural to assume that neural activity would increase somewhat — even twofold. But quite the opposite takes place; we actually observed that the activity ceased altogether," states Professor Hugdahl.

Losing contact with the outside world

In order to learn more about what was happening, Hugdahl and his colleagues Kristiina Kompus and René Westerhausen carried out a meta-analysis of 23 studies. These studies focused either on spontaneous inner-voice triggered neural activation in subjects with schizophrenia or the stimulatory reaction prompted by actual sounds in both healthy and schizophrenic subjects.

It emerged that many researchers had observed either that a spontaneous activation of neurons occurs in patients hearing inner voices or that the patients’ perception of actual voices becomes suppressed when these are heard simultaneously with inner voices. No one had seen the connection between these findings.

"Previously, we thought these were two separate phenomena. But our analyses revealed that the one causes the other: when neurons become activated by inner voices it inhibits perception of outside speech. The neurons become ‘preoccupied’ and can’t ‘process’ voices from the outside," explains Professor Hugdahl.

"This may explain why schizophrenic patients close themselves off so completely and lose touch with the outside world when experiencing hallucinations," he purports.

Electronic app designed to improve impulse control

Hugdal and his colleagues made yet another discovery that may well help explain how the lives of these individuals become consumed by inner voices. It turns out that the frontal lobe in the brains of schizophrenia patients does not function exactly the way it should. As a result, these patients have a lesser degree of impulse control and are unable to filter out their inner voices.

"Every one of us hears inner voices or melodies from time to time. The difference between non-afflicted individuals and schizophrenia patients is that the former manage to tune these out better," the professor points out.

If patients could learn to stifle inner noise it could have a huge impact on our ability to treat schizophrenia, he states. To this end, Professor Hugdahl’s research group has developed an application that can be used on mobile phones and other simple electronic devices, to help patients improve their filters.

Wearing headphones, the patient is exposed to simple speech sounds with different sounds played in each ear. The task is to practice hearing the sound in one ear while blocking out sound in the other. The application has only been tested on two patients with schizophrenia so far. The response from these patients is promising, Dr Hugdahl relates.

"The voices are still there, but the test subjects feel that they have control over the voices instead of the other way around. The patient feels it is a breakthrough since it means he can actively shift his focus from the inner voices over to the sounds coming from the outside," the professor explains.

Source: ScienceDaily

Article Date: 03 Feb 2012 - 0:00 PST

For Bradley Duchaine, there is definitely more than meets the eye where faces are concerned.

With colleagues at Birkbeck College in the University of London, he is investigating the process of facial recognition, seeking to understand the complexity of what is actually taking place in the brain when one person looks at another.

His studies target people who display an inability to recognize faces, a condition long known as prosopagnosia. Duchaine is trying to understand the neural basis of the condition while also make inferences about what is going wrong in terms of information processing - where in the stages that our brains go through to recognize a face is the system breaking down. A paper published in Brain details the most recent experimental results.

“We refer to prosopagnosia as a ‘selective’ deficit of face recognition, in that other cognitive process do not seem to be affected,” explains Duchaine, an associate professor of psychological and brain sciences. “[People with the condition] might be able to recognize voices perfectly, which demonstrates that it is really a visual problem. In what we call pure cases, people can recognize cars perfectly, and they can recognize houses perfectly. It is just faces that are a problem.”

The condition may be acquired as the result of a stroke, for example. But in the recent study, Duchaine focused on developmental prosopagnosia, in which a person fails to develop facial recognition abilities.

“Other parts of the brain develop apparently normally,” Duchaine says. “These are intelligent people who have good jobs and get along fine but they can’t recognize faces.”

The primary experimental tool in this experiment was the electroencephalogram (EEG), which has the advantage of providing excellent temporal resolution - pinpointing the timing of the brain’s electrical response to a given stimulus.

Duchaine and his colleagues placed a series of electrodes around the scalps of prosopagnosics and showed them images of famous faces and non-famous faces, recording their responses. As expected, many of the famous faces were not recognized.

They found an electrical response at about 250 milliseconds (ms) after seeing the faces. Among the control group of non-prosopagnosics, a real difference was observed between their responses to famous and non-famous faces. In half the prosopagnosics there was not. Surprisingly, however, in the other half of the prosopagnosic test subjects they did find a difference.

“On the many trials where half failed to categorize a famous face as familiar, they nevertheless showed an EEG difference around 250ms after stimulus presentation between famous and non-famous faces like normal subjects do. Normal subjects also show a difference between famous and non-famous about 600ms after presentation, but the prosopagnosics did not show this difference,” Duchaine observes.

This pattern of results suggests the prosopagnosics unconsciously recognized the famous faces at an early stage (250ms) but this information was lost by the later stage (600ms). Duchaine concludes that even though they are not consciously aware that this is a famous face, some part of their brain at this stage in the process is aware and is recognizing that face, a phenomenon termed covert face recognition.

He suggests that the other half of the prosopagnosics, who showed no difference between responses at 250ms, were experiencing a malfunction in their face processing system already at this early stage suggesting a different type of prosopagnosia.

“The temporal lobe contains a number of face processing areas, so you can imagine there are many different ways that this system can malfunction. Not only can an area not work, connections between areas might not work yielding probably dozens of these different variants of this condition,” he surmises.

Covert recognition has been demonstrated in prosopagnosia acquired through brain damage, but Duchaine’s work is the first convincing demonstration of covert recognition in developmental prosopagnosia, the much more common form. 

Source: Medical News Today

Article Date: 03 Feb 2012 - 0:00 PST

New findings, led by neuroscientists at the University of Bristol and published this week in the journal Neurobiology of Aging, reveal a novel mechanism through which the brain may become more reluctant to function as we grow older.

It is not fully understood why the brain’s cognitive functions such as memory and speech decline as we age. Although work published this year suggests cognitive decline can be detectable before 50 years of age. The research, led by Professor Andy Randall and Dr Jon Brown from the University’s School of Physiology and Pharmacology, identified a novel cellular mechanism underpinning changes to the activity of neurones which may underlie cognitive decline during normal healthy aging.

The brain largely uses electrical signals to encode and convey information. Modifications to this electrical activity are likely to underpin age-dependent changes to cognitive abilities.

The researchers examined the brain’s electrical activity by making recordings of electrical signals in single cells of the hippocampus, a structure with a crucial role in cognitive function. In this way they characterised what is known as “neuronal excitability” - this is a descriptor of how easy it is to produce brief, but very large, electrical signals called action potentials; these occur in practically all nerve cells and are absolutely essential for communication within all the circuits of the nervous system.

Action potentials are triggered near the neurone’s cell body and once produced travel rapidly through the massively branching structure of the nerve cell, along the way activating the synapses the nerve cell makes with the numerous other nerve cells to which it is connected.

The Bristol group identified that in the aged brain it is more difficult to make hippocampal neurones generate action potentials. Furthermore they demonstrated that this relative reluctance to produce action potential arises from changes to the activation properties of membrane proteins called sodium channels, which mediate the rapid upstroke of the action potential by allowing a flow of sodium ions into neurones.

Professor Randall, Professor in Applied Neurophysiology said: “Much of our work is about understanding dysfunctional electrical signalling in the diseased brain, in particular Alzheimer’s disease. We began to question, however, why even the healthy brain can slow down once you reach my age. Previous investigations elsewhere have described age-related changes in processes that are triggered by action potentials, but our findings are significant because they show that generating the action potential in the first place is harder work in aged brain cells.

“Also by identifying sodium channels as the likely culprit for this reluctance to produce action potentials, our work even points to ways in which we might be able modify age-related changes to neuronal excitability, and by inference cognitive ability.”  

Source: Medical News Today

February 2nd, 2012 in Genetics

A representative gene shows how sex can influence levels of methylation across the lifespan. Each dot represents a different brain. Credit: Barbara Lipska, Ph.D., NIMH Clinical Brain Disorders Branch

For the first time, scientists have tracked the activity, across the lifespan, of an environmentally responsive regulatory mechanism that turns genes on and off in the brain’s executive hub. Among key findings of the study by National Institutes of Health scientists: genes implicated in schizophrenia and autism turn out to be members of a select club of genes in which regulatory activity peaks during an environmentally-sensitive critical period in development. The mechanism, called DNA methylation, abruptly switches from off to on within the human brain’s prefrontal cortex during this pivotal transition from fetal to postnatal life. As methylation increases, gene expression slows down after birth.

Epigenetic mechanisms like methylation leave chemical instructions that tell genes what proteins to make -what kind of tissue to produce or what functions to activate. Although not part of our DNA, these instructions are inherited from our parents. But they are also influenced by environmental factors, allowing for change throughout the lifespan.

“Developmental brain disorders may be traceable to altered methylation of genes early in life,” explained Barbara Lipska, Ph.D., a scientist in the NIH’s National Institute of Mental Health (NIMH) and lead author of the study. “For example, genes that code for the enzymes that carry out methylation have been implicated in schizophrenia. In the prenatal brain, these genes help to shape developing circuitry for learning, memory and other executive functions which become disturbed in the disorders. Our study reveals that methylation in a family of these genes changes dramatically during the transition from fetal to postnatal life - and that this process is influenced by methylation itself, as well as genetic variability. Regulation of these genes may be particularly sensitive to environmental influences during this critical early life period.”

Lipska and colleagues report on the ebb and flow of the human prefrontal cortex’s (PFC) epigenome across the lifespan, February 2, 2012, online in the American Journal of Human Genetics.

Two representative genes show strikingly opposite trajectories of PFC methylation across the lifespan. Each dot represents a different brain. Usually, the more methylation, the less gene expression. Credit: Barbara Lipska, Ph.D., NIMH Clinical Brain Disorders Branch

“This new study reminds us that genetic sequence is only part of the story of development. Epigenetics links nurture and nature, showing us when and where the environment can influence how the genetic sequence is read,” said NIMH director Thomas R. Insel, M.D.

In a companion study published last October, the NIMH researchers traced expression of gene products in the PFC across the lifespan. The current study instead examined methylation at 27,000 sites within PFC genes that regulate such expression. Both studies examined post-mortem brains of non-psychiatrically impaired individuals ranging in age from two weeks after conception to 80 years old.

In most cases, when chemicals called methyl groups attach to regulatory regions of genes, they silence them. Usually, the more methylation, the less gene expression. Lipska’s team found that the overall level of PFC methylation is low prenatally when gene expression is highest and then switches direction at birth, increasing as gene expression plummets in early childhood. It then levels off as we grow older. But methylation in some genes shows an opposite trajectory. The study found that methylation is strongly influenced by gender, age and genetic variation.

For example, methylation levels differed between males and females in 85 percent of X chromosome sites examined, which may help to explain sex differences in disorders like autism and schizophrenia.

Different genes - and subsets of genes - methylate at different ages. Some of the suspect genes found to peak in methylation around birth code for enzymes, called methytransferases, that are over-expressed in people with schizophrenia and bipolar disorder. This process is influenced, in turn, by methylation in other genes, as well as by genetic variation. So genes associated with risk for such psychiatric disorders may influence gene expression through methylation in addition to inherited DNA.

Provided by National Institutes of Health

“Gene regulator in brain’s executive hub tracked across lifespan.” February 2nd, 2012. http://medicalxpress.com/news/2012-02-gene-brain-hub-tracked-lifespan.html

ScienceDaily (Feb. 2, 2012) — One of the most distinctive signs of the development of Alzheimer’s disease is a change in the behavior of a protein that neuroscientists call tau. In normal brains, tau is present in individual units essential to neuron health. In the cells of Alzheimer’s brains, by contrast, tau proteins aggregate into twisted structures known as “neurofibrillary tangles.” These tangles are considered a hallmark of the disease, but their precise role in Alzheimer’s pathology has long been a point of contention among researchers.

Now, University of Texas Medical Branch at Galveston researchers have found new evidence that confirms the significance of tau to Alzheimer’s. Instead of focusing on tangles, however, their work highlights the intermediary steps between a single tau protein unit and a neurofibrillary tangle — assemblages of two, three, four, or more tau proteins known as “oligomers,” which they believe are the most toxic entities in Alzheimer’s.

"What we discovered is that there are smaller structures that form before the neurofibrillary tangles, and they are much more toxic than the big structures," said Rakez Kayed, UTMB assistant professor and senior author of a paper on the work now online in the FASEB Journal. “And we established that they were toxic in real human brains, which is important to developing an effective therapy.”

According to Kayed, a key antibody developed at UTMB called T22 enabled the team to produce a detailed portrait of tau oligomer behavior in human brain tissue. Specifically designed to bond only to tau oligomers (and not lone tau proteins or neurofibrillary tangles), the antibody made it possible for the researchers to use a variety of analytical tools to compare samples of Alzheimer’s brain with samples of age-matched healthy brain.

"One thing that’s remarkable about this research is that before we developed this antibody, people couldn’t even see tau oligomers in the brain," Kayed said. "With T22, we were able to thoroughly characterize them, and also study them in human brain cells."

Among the researchers’ most striking findings: in some of the Alzheimer’s brains they examined, tau oligomer levels were as much as four times as high as those found in age-matched control brains.

Other experiments revealed specific biochemical behavior and structures taken on by oligomers, and demonstrated their presence outside neurons — in particular, on the walls of blood vessels.

"We think this is going to make a big impact scientifically, because it opens up a lot of new areas to study," Kayed said. "It also relates to our main focus, developing a cure for Alzheimer’s. And I find that very, very exciting."

Provided by University of Texas Medical Branch at Galveston

Source: ScienceDaily